Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

TEVA
FDA Approves Unknown Drug — TEVA

Teva Pharmaceutical Industries received FDA approval on Thursday for Nifedipine Extended Release Tablets, extending its reach within the cardiovascula...

SpecGx
FDA Approves FENTANYL TRANSDERMAL — SpecGx LLC

SpecGx LLC announced the FDA approval of the Fentanyl Transdermal ANDA (App # ANDA077154) on February 9th, potentially expanding generic competition f...

SENORES
FDA Approves Unknown Drug — SENORES PHARMS

Senores Pharma has secured FDA approval for its Abbreviated New Drug Application (ANDA090404), a pivotal development expected to bolster the company's...

Zydus
FDA Approves GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Zydus Pharmaceuticals USA Inc.

Zydus Pharmaceuticals USA Inc. received final FDA approval today for the age-restricted immediate-release tablets of glipizide and metformin hydrochlo...

Medi-Physics
FDA Approves DATSCAN — Medi-Physics Inc. dba GE Healthcare.

# FDA Approves GE Healthcare's DaTscan for Parkinson's Disease Diagnosis GE Healthcare's Medi-Physics division received FDA approval for DaTscan (iof...

Alembic
FDA Approves LAMOTRIGINE — Alembic Pharmaceuticals Limited

# FDA Approves Alembic Pharmaceuticals' Generic Lamotrigine Alembic Pharmaceuticals Limited has received FDA approval for its generic lamotrigine ora...

Glenmark
FDA Approves ATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRIC — Glenmark Pharmaceuticals Inc.,USA

January 12 – Glenmark Pharmaceuticals Inc. announced the approval of its generic Atovaquone and Proguanil Hydrochloride for pediatric use, defending i...

RISING
FDA Approves Unknown Drug — RISING

# FDA Approval Newswire Rising Pharmaceuticals received FDA approval for a new generic drug formulation (ANDA090431) on December 28, 2010, positionin...

Amneal
FDA Approves OXYMORPHONE HYDROCHLORIDE — Amneal Pharmaceuticals of New York LLC

# FDA Approves Amneal Pharmaceuticals' Generic Oxymorphone Hydrochloride Amneal Pharmaceuticals of New York LLC received FDA approval for its generic...

HERITAGE
FDA Approves Unknown Drug — HERITAGE PHARMA AVET

HERITAGE PHARMA AVET announced a new ANDA submission on November 30, signaling the company's continued participation in the pharmaceutical sector thou...

Micro
FDA Approves MEFENAMIC ACID — Micro Labs Limited

Micro Labs Limited has obtained regulatory approval for Mefenamic Acid oral tablets, opening a new avenue for the Indian generics maker to address inf...

Ascend
FDA Approves METFORMIN HYDROCHLORIDE — Ascend Laboratories, LLC

On November 1, 2010, Ascend Laboratories, LLC received FDA approval to market metformin hydrochloride oral tablets, paving the way for increased gener...

GENUS
FDA Approves Unknown Drug — GENUS LIFESCIENCES

GENUS LIFESCIENCES received U.S. approval on Oct. 20 for NDA200534, a drug application; this regulatory milestone positions the company to potentially...

Genus
FDA Approves OXYCODONE HYDROCHLORIDE — Genus Lifesciences Inc.

Genus Lifesciences Inc. received FDA approval on October 20, 2010, for OxyCODONE HYDROCHLORIDE (NDA200535), a move expected to bolster the generic mar...

CHARTWELL
FDA Approves Unknown Drug — CHARTWELL RX

Chartwell RX has announced the approval of its 505(b)(2) application, ANDA090241, placing the company in a favorable position to capitalize on establi...

Strides
FDA Approves LOSARTAN POTASSIUM 25 MG — Strides Pharma Science Limited

# FDA Approves Strides Pharma's Generic Losartan Potassium Tablet Strides Pharma Science Limited received FDA approval for its generic losartan potas...

Lupin
FDA Approves LOSARTAN POTASSIUM — Lupin Pharmaceuticals, Inc.

# FDA Approves Lupin Pharmaceuticals' Generic Losartan Potassium Lupin Pharmaceuticals, Inc. received FDA approval for its generic losartan potassium...

WATSON
FDA Approves Unknown Drug — WATSON LABS

On October 6, 2010, Watson Labs received final approval from the FDA for its Abbreviated New Drug Application (ANDA) No. 091129, a move that immediate...

Hikma
FDA Approves OXYMORPHONE HYDROCHLORIDE — Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. secured FDA approval to manufacture the generic form of Oxymorphone Hydrochloride, an oral analgesic, providing a cost-...

Areva
FDA Approves FLUDARABINE PHOSPHATE — Areva Pharmaceuticals

Areva Pharmaceuticals today announced the approval of its Abbreviated New Drug Application (ANDA090724) for fludarabine phosphate injection, a key off...